News

Genentech is currently marketing Xeloda in the US. Teva claims that it was the first to receive approval on its abbreviated new drug application from the US Food

The research group of Dr Francesco Saverio Tedesco from the UCL department of Cell and Developmental Biology is conducting the research, which is being supported through funding of

Curcumin is an active product that is generated from the spice, turmeric. It has been consumed for centuries in other parts of the world without posing any side

The FDA’s Fast Track process is designed to facilitate the development and expedite the review of drugs to treat serious conditions that fill an unmet medical need, with

The patent includes claims to the use of the company’s drug candidate, Trimesta (oral estriol), in conjunction with a gestagen for the treatment of multiple sclerosis (MS) and

The DSMB’s review of the efficacy data is still pending. Northwest Biotherapeutics chief technical officer Dr. Marnix Bosch noted the company is pleased with the recommendation of the

The trial met its primary efficacy endpoint by showing a significantly lower ‘Total Combined Rhinitis Score’ (TCRS) when compared with patients who received placebo. The trial also showed

The secure online e-prescribing portal is available to healthcare providers in the US, interested in a clinically validated, peer reviewed, non-pharmacologic alternative to narcotic and NSAID pain medications

Furiex Pharmaceuticals, under its agreement with Takeda, is eligible to receive royalties and sales-based milestones if trelagliptin succinate is approved and marketed in Japan. Takeda Pharmaceutical has submitted